Clinical Trials in Pittsburgh

Showing 10561-10580 of 16,007 trials

The Mobile PTSD Coach App in Acute Injury Survivors

NCT03247179

This project is a preliminary randomized controlled trial testing the potential impact of the PTSD Coach mobile application at reducing posttraumatic stress and pain symptoms among acutely injured trauma patients. Immediately following the injury, patients will be randomly assigned to use the PTSD Coach app, or to the treatment as usual condition.

Chronic PainAcute Pain Due to TraumaPosttraumatic Stress Disorder

University of Pittsburgh64 participantsStarted Sep 2017

Pittsburgh, Pennsylvania, United States • Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

NCT02437890

Primary objective: To assess the efficacy and safety of different dose regimens of ALX-0061 administered subcutaneously (s.c.) to subjects with moderate to severe active, seropositive systemic lupus erythematosus (SLE) compared to placebo. Secondary objectives: To assess the pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, flare rate, steroid reduction and health-related quality of life, with different dose regimens of ALX-0061.

Lupus Erythematosus, Systemic

Ablynx, a Sanofi company312 participantsStarted Jul 2015

Birmingham, Alabama, United States • Glendale, Arizona, United States • Phoenix, Arizona, United States +115 more locations

The Mobile PTSD Coach App in Acute Injury Survivors

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

Find Trials by Condition in Pittsburgh

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock

Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument

Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU

A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors

Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)

Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years

Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA

VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults

Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer

A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation

Project LIFT - Promoting Healthy Behavior Through a Wearable Fitness Device and Financial Incentives

Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)

Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Monitoring of Multiple Sclerosis (MS) Participants With the Use of Digital Technology (Smartphones and Smartwatches) - A Feasibility Study